8-K: HealthEquity Unveils Strong FY27 Outlook, Reaffirms FY26 Guidance

HealthEquity, Inc. announced its initial fiscal year 2027 outlook, projecting revenues between $1.38 billion and $1.41 billion, while reaffirming its fiscal year 2026 guidance.

Summary

• HealthEquity, Inc. provided its initial financial outlook for the fiscal year ending January 31, 2027.
• Management expects revenues for FY27 to be in the range of $1.38 billion to $1.41 billion.
• Adjusted EBITDA margin for FY27 is projected between 43.8% and 44.3%.
• The yield on HSA Cash for FY27 is anticipated to be approximately 3.75%.
• The company reaffirmed its previously provided guidance for the fiscal year ending January 31, 2026.
• These estimates will be discussed at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026.

Sentiment

Score: 8

Explanation: The filing presents a positive outlook for the upcoming fiscal year with strong revenue and EBITDA margin projections, coupled with a reaffirmation of current year guidance, indicating stability and confidence in the company's strategic direction and market position. Management commentary reinforces a narrative of strengthening foundations and driving long-term value.

Positives

• Strong initial outlook for fiscal year 2027 with projected revenues of $1.38 billion to $1.41 billion.
• Anticipated Adjusted EBITDA margin of 43.8% to 44.3% for FY27 indicates healthy profitability.
• Reaffirmation of fiscal year 2026 guidance suggests stability and confidence in current performance.
• Management highlights progress in strengthening the company's foundation, modernizing the business, and accelerating the digital experience.
• Positioned for durable growth and long-term shareholder value through scale and an ecosystem of over 200 integrated Network Partners.

Risks

• Ability to adequately place and safeguard custodial assets, or the failure of any depository or insurance company partners.
• Ability to compete effectively in a rapidly evolving healthcare and benefits administration industry.
• Dependence on the continued availability and benefits of tax-advantaged HSAs and other consumer-directed benefits (CDBs).
• Impact of fraudulent account activity involving member accounts or third-party service providers on reputation and financial results.
• Ability to successfully identify, acquire, and integrate additional portfolio purchases or acquisition targets.
• Significant competition, including from those with greater resources.
• Reliance on the availability and performance of technology and communications systems.
• Potential future cybersecurity breaches of technology and communications systems and other data interruptions, including resulting costs, liabilities, reputational damage, and loss of business.
• The current uncertain healthcare environment, including changes in healthcare programs, expenditures, and related regulations.
• Ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser, and other laws applicable to the business.
• Reliance on partners and third-party vendors for distribution and important services.
• Ability to develop and implement updated features for technology platforms and communications systems.
• Reliance on the management team and key team members.

Future Outlook

HealthEquity provided an initial outlook for its fiscal year ending January 31, 2027, projecting revenues between $1.38 billion and $1.41 billion, an Adjusted EBITDA margin of 43.8% to 44.3%, and a yield on HSA Cash of approximately 3.75%. The company also reaffirmed its previously issued guidance for the fiscal year ending January 31, 2026, indicating confidence in its near-term performance.

Management Comments

• "Today, we issued our initial fiscal 2027 outlook, reflecting the progress we've made strengthening HealthEquity's foundation and building momentum as a scaled platform." Scott Cutler, President and CEO.
• "Over the past year, we've modernized the business, raising the bar on security and trust, accelerating the digital experience, and driving engagement, so the model compounds over time." Scott Cutler, President and CEO.
• "Healthcare affordability is a structural challenge, making HSAs increasingly central to how Americans finance care." Scott Cutler, President and CEO.
• "With our scale and an ecosystem of 200+ integrated Network Partners, including health and retirement plan partners, brokers and benefit advisors, we believe HealthEquity is positioned to drive durable growth and create long-term value for shareholders." Scott Cutler, President and CEO.

Industry Context

HealthEquity operates in the rapidly evolving healthcare and benefits administration industry, where tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) are becoming increasingly central to addressing healthcare affordability challenges in the U.S. The company's scale as the nation's largest HSA custodian and its extensive network of over 200 integrated partners position it to capitalize on these trends, driving growth in a market facing structural challenges in healthcare financing.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through durable growth, as stated by management, supported by a positive FY27 outlook.
• Customers (HSA/CDB account holders): Continued focus on modernizing the business, accelerating digital experience, and raising security standards aims to improve service and trust.
• Partners (employers, benefits advisors, health/retirement plan providers): HealthEquity's scale and ecosystem of 200+ integrated Network Partners suggest continued collaboration and potential for expanded offerings.
• Employees: Management's focus on strengthening the foundation and modernizing the business could imply ongoing strategic initiatives and potential for growth within the company.

Next Steps

• HealthEquity management will discuss the FY27 estimates and expectations at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026.
• An audio webcast and presentation materials from the conference will be available on the company's investor relations website.

Key Dates

Recommendation

The initial fiscal year 2027 outlook, featuring robust revenue and Adjusted EBITDA margin projections, combined with the reaffirmation of fiscal year 2026 guidance, signals strong operational momentum and financial health. Management's strategic focus on modernizing the business, enhancing security, and leveraging its extensive partner ecosystem positions HealthEquity for durable growth in a structurally important healthcare finance sector. The company's leadership as the largest HSA custodian further solidifies its market position, making it an attractive investment for long-term value creation.

Keywords

HealthEquity, HQY, HSA, Health Savings Account, CDB, Consumer-Directed Benefits, Financial Outlook, Fiscal Year 2027, Revenue Guidance, EBITDA Margin, J.P. Morgan Healthcare Conference, Healthcare Finance, Benefits Administration, Investor Relations